Today, the U.S. Food and Drug Administration (FDA) approved letermovir (Prevymis) once-daily tablets for oral use and injection for intravenous infusion. Letermovir…
admin
The U.S. Food and Drug Administration today approved Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed…
THOUSAND OAKS, Calif., Oct. 7, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced new combination study results from the Phase 1b CodeBreaK 101 study,…
5th Global Summit on Cancer and Oncology Research October 21-22, 2021 Vienna, Austria Meet Inspiring Speakers and Experts at our 3000+…
HUMIRA® (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis – HUMIRA (adalimumab)…
FDA Approves Libtayo® (cemiplimab-rwlc) Monotherapy for Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50% Regeneron…
US regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now…
A new way to help the body’s immune system get past that deception and destroy cancer, has been found by…
The Indian healthcare scenario presents a spectrum of contrasting landscapes. At one end of the spectrum are the glitzy steel…
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!